New study aims to perfect heart pacing lead placement
NCT ID NCT07378124
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This trial tests two different heart pacing leads—one without a hollow core (lumenless) and one with a stylet—to see which works better for left bundle branch pacing. About 288 people with slow heart rhythms will take part. Doctors will use continuous monitoring to guide the lead placement and check for a specific electrical sign (S-V dissociation) to confirm correct positioning. The goal is to improve success rates and reduce risks like heart perforation.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Procedure: implantation of a lumenless lead or a stylet-driven lead for heart pacing
What this could lead to
If successful, this could establish a safer, more effective standard technique for left bundle branch pacing, reducing complications like heart perforation.
What could go wrong
This is an early-stage trial with 288 participants, so results may not apply to all patients. The procedure itself carries risks such as infection or lead dislodgement.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BRADYCARDIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ningbo No.2 Hospital
Ningbo, Zhejiang, 315000, China
Contact Phone: •••-•••-•••• Email: •••••@•••••